HIV-1 Tat depresses DNA-PKCS expression and DNA repair, and sensitizes cells to ionizing radiation

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 3, 2006, Pages 842-850

  Sun, Yi ^a   Huang, Yue Chen ^a   Xu, Qin Zhi ^a   Wang, Hui Ping ^a   Bai, Bei ^a   Sui, Jian Li ^a   Zhou, Ping Kun ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Cell cycle arrest; DNA repair; DNA PKcs; HIV 1 Tat; Radiosensitivity

Indexed keywords

BIOASSAY; CELLS; DNA; IMMUNOLOGY; PROTEINS; RADIATION PROTECTION; TISSUE; TUMORS; VIRUSES;

CELL CYCLE ARREST; DNA REPAIR; DNA-PKCS; HIV-1 TAT; RADIOSENSITIVITY;

RADIOTHERAPY;

CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 20; CELL CYCLE PROTEIN 25C; CYCLIN B1; DNA DEPENDENT PROTEIN KINASE; DOUBLE STRANDED DNA; G2 AND S PHASE EXPRESSED 1 PROTEIN; KINESIN LIKE 6 PROTEIN; PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; COLONY FORMING UNIT; COMET ASSAY; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DNA REPAIR; DNA STRAND BREAKAGE; DOWN REGULATION; ENZYME ACTIVE SITE; FLOW CYTOMETRY; GAMMA IRRADIATION; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IONIZING RADIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION RESPONSE; RADIOSENSITIVITY; RADIOSENSITIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CELL LINE; CELL PROLIFERATION; COMET ASSAY; DNA DAMAGE; DNA REPAIR; DNA-ACTIVATED PROTEIN KINASE; G2 PHASE; GENE EXPRESSION; GENE PRODUCTS, TAT; HIV-1; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RADIATION TOLERANCE;

EID: 33646904547     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.02.040     Document Type: Article

References (44)

1. Formenti S.C., Chak L., Gill P., et al. Increased radiosensitivity of normal tissue fibroblasts in patients with acquired immunodeficiency syndrome (AIDS) and with Kaposi's sarcoma. Int J Radiat Biol 68 (1995) 411-412
2. Smith K.J., Skelton H.G., Tuur S., et al., Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). Increased cutaneous toxicity to ionizing radiation in HIV-positive patients. Int J Dermatol 36 (1997) 779-782
3. Thoma-Greber E., Gottlober P., Rocken M., and Peter R.U. Bullous skin reactions after soft roentgen radiotherapy of HIV-associated Kaposi sarcomas. Hautarzt 48 (1997) 339-342
4. Lukawska J., Cottrill C., and Bower M. The changing role of radiotherapy in AIDS-related malignancies. Clin Oncol (R Coll Radiol) 15 (2003) 2-6
5. Shrivastava S.K., Engineer R., Rajadhyaksha S., and Dinshaw A. HIV infection and invasive cervical cancers, treatment with radiation therapy. Toxicity and outcome. Radiother Oncol 74 (2005) 31-35
6. Wijsman J.A., Dekaban G.A., and Rieder M.J. Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells. Influence of HIV infection on clindamycin toxicity in vitro. J Clin Pharmacol 45 (2005) 346-351
7. Sun Y., Xu Q.Z., Li J.Y., et al. Cloning of Tat gene of a HIV-1 B strain from Henan province and homologous analysis of its encoding product. [in Chinese]. Lett Biotechnol 16 (2005) 245-248
8. Roberts S.A. DRFIT. A program for fitting radiation survival models. Int J Radiat Biol 57 (1990) 1243-1246
9. Cannavò G., Paiardini M., Galati D., et al. Abnormal intracellular kinetics of cell-cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus. A novel biologic link between immune activation, accelerated T-cell turnover, and high levels of apoptosis. Blood 97 (2001) 1756-1764
10. Galati D., Paiardini M., Cervasi B., et al. Specific changes in the posttranslational regulation of nucleolin in lymphocytes from patients infected with human immunodeficiency virus. J Infect Dis 188 (2003) 1483-1491
11. Paiardini M., Cervasi B., Galati D., et al. Piedimonte. Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients. AIDS 18 (2004) 393-402
12. Ensoli B., Buonaguro L., Barillari G., et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67 (1993) 277-287
13. Zauli G., Gibellini D., Milani D., et al. Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res 53 (1993) 4481-4485
14. Lotz M., Clark-Lewis I., and Ganu V. HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes. J Cell Biol 124 (1994) 365-371
15. Seve M., Favier A., Osman M., et al. The human immunodeficiency virus-1 Tat protein increases cell proliferation, alters sensitivity to zinc chelator-induced apoptosis, and changes Sp1 DNA binding in HeLa cells. Arch Biochem Biophys 361 (1999) 165-172
16. Cantaluppi V., Biancone L., Boccellino M., et al. HIV type 1 Tat protein is a survival factor for Kaposi's sarcoma and endothelial cells. AIDS Res Hum Retroviruses 17 (2001) 965-976
17. Reilly T.P., MacArthur R.D., Farrough M.J., et al. Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?. J Pharmacol Exp Ther 291 (1999) 1356-1364
18. Arp J., Rieder M.J., Urquhart B., et al. Hypersensitivity of HIV-1-infected cells to reactive sulfonamide metabolites correlated to expression of the HIV-1 viral protein tat. J Pharmacol Exp Ther 314 (2005) 1218-1225
19. Jackson S.P. Sensing and repairing DNA double-strand breaks. Carcinogenesis 23 (2002) 687-696
20. Espejel S., Klatt P., Murcia J.M., et al. Impact of telomerase ablation on organismal viability, aging, and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86, or DNA-PKcs. J Cell Biol 167 (2004) 627-638
21. Park S.J., Oh E.J., Yoo M.A., and Lee S.H. Involvement of DNA-dependent protein kinase in regulation of stress-induced JNK activation. DNA Cell Biol 20 (2001) 637-645
22. Meek K., Gupta S., Ramsden D.A., and Lees-Miller S.P. The DNA-dependent protein kinase. The director at the end. Immunol Rev 200 (2004) 132-141
23. Bailey S.M., Brenneman M.A., Halbrook J., et al. The kinase activity of DNA-PK is required to protect mammalian telomeres. DNA Repair (Amst) 3 (2004) 225-233
24. Hande M.P. DNA repair factors and telomere-chromosome integrity in mammalian cells. Cytogenet Genome Res 104 (2004) 116-122
25. Hendry J.H., and Jiang T.N. Differential radiosensitising effect of the scid mutation among tissues, studied using high and low dose rates. Implications for prognostic indicators in radiotherapy. Radiother Oncol 33 (1994) 209-216
26. Loregian A., Bortolozzo K., Boso S., et al. Interaction of Sp1 transcription factor with HIV-1 Tat protein. Looking for cellular partners. FEBS Lett 543 (2003) 61-65
27. Sancho R., Marquez N., Gomez-Gonzalo M., Calzado M.A., et al. Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway. J Biol Chem 279 (2004) 37349-37359
28. Mischitelli M., Fioriti D., Videtta M., et al. 2005. Investigation on the role of cell transcriptional factor Sp1 and HIV-1 TAT protein in PML onset or development. J Cell Physiol 204 (2005) 913-918
29. Marecki J.C., Cota-Gomez A., Vaitaitis G.M., et al. HIV-1 Tat regulates the SOD2 basal promoter by altering Sp1/Sp3 binding activity. Biol Med 37 (2004) 869-880
30. Porntadavity S., Nath A., Prachayasittikul V., et al. Different roles of Sp family members in HIV-1 Tat-mediated manganese superoxide dismutase suppression in hepatocellular carcinoma cells. DNA Cell Biol 24 (2005) 299-310
31. Fujimoto M., Matsumoto N., Tsujita T., et al. Characterization of the promoter region, first ten exons and nine intron-exon boundaries of the DNA-dependent protein kinase catalytic subunit gene, DNA-PKcs (XRCC7). DNA Res 4 (1997) 151-154
32. Nurse P. Universal control mechanism regulating onset of M-phase. Nature 344 (1990) 503-508
33. Murray A.W., Solomon M.J., and Kirschner M.W. The role of cyclin synthesis and degradation in the control of maturation promoting factor activity. Nature 339 (1989) 280-286
34. Hutchins J.R., and Clarke P.R. Many fingers on the mitotic trigger. Post-translational regulation of the Cdc25C phosphatase. Cell Cycle 3 (2004) 41-45
35. Nilsson I., and Hoffmann I. Cell cycle regulation by the Cdc25 phosphatase family. Cell Cycle Res 4 (2000) 107-114
36. Lee J., Kumagai A., and Dunphy W.G. Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. Mol Biol Cell 12 (2001) 551-563
37. McGowan C.H., and Russell P. Cell cycle regulation of human Wee1. EMBO J 14 (1995) 2166-2175
38. Yamamoto T.M., Iwabuchi M., Ohsumi K., and Kishimoto T. APC/C-Cdc20-mediated degradation of cyclin B participates in CSF arrest in unfertilized Xenopus eggs. Dev Biol 279 (2005) 345-355
39. Howell B.J., Moree B., Farrar E.M., et al. Salmon. Spindle checkpoint protein dynamics at kinetochores in living cells. Curr Biol 14 (2004) 953-964
40. Doncic A., Ben-Jacob E., and Barkai N. Evaluating putative mechanisms of the mitotic spindle checkpoint. Natl Acad Sci U S A 102 (2005) 6332-6337
41. Tang Z., Shu H., Oncel D., et al. Phosphorylation of Cdc20 by Bub1 provides a catalytic mechanism for APC/C inhibition by the spindle checkpoint. Mol Cell 16 (2004) 387-397
42. Hunter A.W., Caplow M., Coy D.L., et al. The kinesin-related protein MCAK is a microtubule depolymerase that forms an ATP-hydrolyzing complex at microtubule ends. Mol Cell 11 (2003) 445-457
43. Lan W., Zhang X., Kline-Smith S.L., et al. Aurora B phosphorylates centromeric MCAK and regulates its localization and microtubule depolymerization activity. Curr Biol 14 (2004) 273-286
44. Kline-Smith S.L., Khodjakov A., Hergert P., and Walczak C.E. Depletion of centromeric MCAK leads to chromosome congression and segregation defects due to improper kinetochore attachments. Mol Biol Cell 15 (2004) 1146-1159